Treatment of chronic spontaneous urticaria with a single dose of omalizumab: A study of four cases

Background: Chronic spontaneous urticaria (CSU) has a detrimental effect on patients′ emotional and physical quality of life. Omalizumab, an anti-immunoglobulin E humanized monoclonal antibody, has been shown to be very effective in the treatment of refractory chronic urticaria patients but may not...

Full description

Bibliographic Details

Published in:	Indian Journal of Dermatology
Main Authors:	Radhakrishnan Subramaniyan, Ajay Chopra
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2016-01-01
Subjects:	Chronic spontaneous urticaria Dermatology Life Quality Index omalizumab Urticaria Activity Score 7
Online Access:	http://www.e-ijd.org/article.asp?issn=0019-5154;year=2016;volume=61;issue=4;spage=467;epage=467;aulast=Subramaniyan